Clinical Trial Update: 13-valent Pneumococcal Conjugate Vaccine Study in Adults => 50 Years of Age in Mexico [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the 13-valent pneumococcal conjugate vaccine in adults aged 50 and older in Mexico completed; results were posted in January 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infections

Drugs mentioned

• Prevnar 13 (pneumococcal conjugate vaccine)

Snippet

Sponsor: Pfizer | Conditions: Pneumococcal Infections | Phase 3 | Status: COMPLETED | Results posted: 2013-01-08